Despite strong clinical data, RSV immunization rates among pregnant women and older adults remain worryingly low, ...

An RSV vaccine has been available to pregnant women in Northern Ireland since last September and is offered from 28 weeks of ...

“Our findings reinforce the importance of RSV vaccination in older adults and suggest that monitoring for signs of heart ...

Parental trust in clinicians drove RSV vaccine uptake, while confusion and limited access to reliable information hindered ...

The CDC recently updated RSV vaccine recommendations to include certain adults aged 50 and up. When is the best time to get ...

“Appropriate people at higher risk should be vaccinated, and this will not only benefit the vaccinated person, but will ...

No RSV vaccine has been approved by the Food and Drug Administration, but the first attempt was made in the 1960s, which was unsuccessful as it led to severe and lethal cases of lung inflammatory ...

In older adults, respiratory syncytial virus (RSV) is associated with an increased risk for cardiovascular outcome, especially heart failure events.

The risk for respiratory syncytial virus-related hospitalizations is elevated in children with chronic medical conditions ...

Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in ...

Sanofi has struck a deal to buy Vicebio for $1.15 billion upfront, securing preclin | Sanofi has struck a deal to buy Vicebio ...

A new UK study shows that vaccinating pregnant women against RSV has led to a staggering 72% drop in hospitalizations of ...